Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction
Hara, N.; Yosida, T.; Said, S.I.
Nihon Kyobu Shikkan Gakkai Zasshi 16(11): 840-845
1978
ISSN/ISBN: 0301-1542 PMID: 739695 Document Number: 131437
Document emailed within 1 workday
Related Documents
Ryan, J.; Cohen, S. 1977: Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure Gastroenterology 73(4 Pt 1): 870-872Mitsuma, T.; Nogimori, T.; Chaya, M. 1984: Effects of vasoactive intestinal polypeptide on hypothalamic-pituitary-thyroid axis in rats Endocrinologia Experimentalis 18(2): 93-100
Carlquist, M.; Jörnvall, H.; Tatemoto, K.; Mutt, V. 1982: A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide Gastroenterology 83(1 Part 2): 245-249
Hayashi, K.; Mochizuki, M.; Masuda, K. 1983: Effects of vasoactive intestinal polypeptide (VIP) and cyclic AMP on isolated dilator pupillae muscle of albino rabbit eye Japanese Journal of Ophthalmology 27(4): 647-654
Cieślewicz, G.; Gondorowicz, K.; Grzelewska-Rzymowska, I.; Rozniecki, J. 1995: Effect of loratadine, selective antagonist of histamine H1 receptors, on histamine-induced bronchoconstriction Pneumonologia i Alergologia Polska 63(5-6): 281-285
Varsky, C.G. 1978: Vasoactive intestinal polypeptide (V.I.P) Acta Gastroenterologica Latinoamericana 8(2): 139-170
Iwanaga, T. 2002: Vasoactive intestinal polypeptide (VIP) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 35-38
Tomkin, G.H.; Ardill, J.; Lafferty, H.; Darragh, A. 1983: Vasoactive intestinal polypeptide in obesity International Journal of Obesity 7(2): 153-160
Unverferth, D.V.; O'Dorisio, T.M.; Muir, W.W.; White, J.; Miller, M.M.; Hamlin, R.L.; Magorien, R.D. 1985: Effect of vasoactive intestinal polypeptide on the canine cardiovascular system Journal of Laboratory and Clinical Medicine 106(5): 542-550
Haghjoo, K.; Cash, P.W.; Farid, R.S.; Komisaruk, B.R.; Jordan, F.; Pochapsky, S.S. 1996: Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties Peptide Research 9(6): 327-331
Basterra, J.; Dilly, P.N.; Perez, M.; Chumbley, C.C. 1989: Vasoactive intestinal polypeptide and neuropeptide-Y, as possible mediators in laryngeal oedema. An immunofluorescence study Acta Oto-Rhino-Laryngologica Belgica 43(2): 99-104
Shimatsu, A.; Kato, Y.; Tatsuoka, Y.; Yoshida, K.; Imura, H. 1985: Somatostatin and vasoactive intestinal polypeptide in the cerebrospinal fluid of patients with neurological disorders Rinsho Shinkeigaku 25(11): 1305-1310
Mirochnik, V.V.; Ugriumov, M.V.; Bosler, O.; Calas, A. 2002: Effect of serotonin on differentiation of neurons producing vasoactive intestinal polypeptide in the rat suprachiasmatic nucleus Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 88(4): 417-423
Kim, S.W.; Beauchamp, R.D.; Townsend, C.M.; Thompson, J.C. 1991: Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells Surgery 110(2): 270-275; Discussion 276
Chand, N.; Pillar, J.; Nolan, K.; Diamantis, W.; Sofia, R.D. 1990: Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086 Research Communications in Chemical Pathology and Pharmacology 67(1): 155-158
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Zawilska, J.B.; Niewiadomski, P.ł; Nowak, J.Z. 2004: Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex Polish Journal of Pharmacology 56(2): 203-211
Martinez, C.; Delgado, M.; Gomariz, R.P.; Ganea, D. 1996: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes Journal of Immunology 156(11): 4128-4136
Tay, S.S.; Moules, E.W.; Burnstock, G. 1994: Colocalisation of NADPH-diaphorase with nitric oxide synthase and vasoactive intestinal polypeptide in newborn pancreatic neurons Journal of Anatomy 184: 545-552
Behar, J.; Field, S.; Marin, C. 1979: Effect of glucagon, secretin, and vasoactive intestinal polypeptide on the feline lower esophageal sphincter: mechanisms of action Gastroenterology 77(5): 1001-1007